PortfoliosLab logoPortfoliosLab logo
LTRN vs. DVLT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

LTRN vs. DVLT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Lantern Pharma Inc. (LTRN) and Datavault AI Inc (DVLT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, LTRN achieves a 12.21% return, which is significantly higher than DVLT's -25.95% return.


LTRN

1D
-9.09%
1M
52.47%
YTD
12.21%
6M
-3.95%
1Y
5.59%
3Y*
-12.24%
5Y*
-25.86%
10Y*

DVLT

1D
-7.85%
1M
-16.57%
YTD
-25.95%
6M
-73.61%
1Y
-44.72%
3Y*
-86.37%
5Y*
-90.76%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

LTRN vs. DVLT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
LTRN
Lantern Pharma Inc.
12.21%-5.02%-25.47%-29.14%-24.31%-58.55%28.76%
DVLT
Datavault AI Inc
-25.95%-68.19%-88.31%-98.92%-92.24%-60.73%57.33%

Correlation

The correlation between LTRN and DVLT is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.14

Correlation (3Y)
Calculated over the trailing 3-year period

0.11

Correlation (5Y)
Calculated over the trailing 5-year period

0.14

Correlation (All Time)
Calculated using the full available price history since Jun 12, 2020

0.14

Fundamentals

Market Cap

LTRN:

$38.26M

DVLT:

$268.28M

EPS

LTRN:

-$1.45

DVLT:

-$0.55

PB Ratio

LTRN:

11.10

DVLT:

1.22

Total Revenue (TTM)

LTRN:

$0.00

DVLT:

$39.38M

Gross Profit (TTM)

LTRN:

$0.00

DVLT:

$15.77M

EBITDA (TTM)

LTRN:

-$16.42M

DVLT:

-$70.96M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Lantern Pharma Inc.

Datavault AI Inc

Return for Risk

LTRN vs. DVLT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LTRN
LTRN Risk / Return Rank: 4646
Overall Rank
LTRN Sharpe Ratio Rank: 4343
Sharpe Ratio Rank
LTRN Sortino Ratio Rank: 5050
Sortino Ratio Rank
LTRN Omega Ratio Rank: 5151
Omega Ratio Rank
LTRN Calmar Ratio Rank: 4343
Calmar Ratio Rank
LTRN Martin Ratio Rank: 4242
Martin Ratio Rank

DVLT
DVLT Risk / Return Rank: 3939
Overall Rank
DVLT Sharpe Ratio Rank: 3232
Sharpe Ratio Rank
DVLT Sortino Ratio Rank: 5959
Sortino Ratio Rank
DVLT Omega Ratio Rank: 5353
Omega Ratio Rank
DVLT Calmar Ratio Rank: 2323
Calmar Ratio Rank
DVLT Martin Ratio Rank: 2727
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LTRN vs. DVLT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Lantern Pharma Inc. (LTRN) and Datavault AI Inc (DVLT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


LTRNDVLTDifference

Sharpe ratio

Return per unit of total volatility

0.06

-0.22

+0.27

Sortino ratio

Return per unit of downside risk

0.83

1.24

-0.41

Omega ratio

Gain probability vs. loss probability

1.12

1.13

-0.01

Calmar ratio

Return relative to maximum drawdown

0.07

-0.51

+0.58

Martin ratio

Return relative to average drawdown

0.15

-0.73

+0.88

LTRN vs. DVLT - Sharpe Ratio Comparison

The current LTRN Sharpe Ratio is 0.06, which is higher than the DVLT Sharpe Ratio of -0.22. The chart below compares the historical Sharpe Ratios of LTRN and DVLT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


LTRNDVLTDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.06

-0.22

+0.27

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.30

-0.47

+0.17

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.26

-0.51

+0.25

Drawdowns

LTRN vs. DVLT - Drawdown Comparison

The maximum LTRN drawdown since its inception was -94.89%, smaller than the maximum DVLT drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for LTRN and DVLT.


Loading charts...

Drawdown Indicators


LTRNDVLTDifference

Max Drawdown

Largest peak-to-trough decline

-94.89%

-100.00%

+5.11%

Max Drawdown (1Y)

Largest decline over 1 year

-78.95%

-87.38%

+8.43%

Max Drawdown (3Y)

Largest decline over 3 years

-89.48%

-99.89%

+10.41%

Max Drawdown (5Y)

Largest decline over 5 years

-93.02%

-100.00%

+6.98%

Current Drawdown

Current decline from peak

-84.49%

-100.00%

+15.51%

Average Drawdown

Average peak-to-trough decline

-66.20%

-90.50%

+24.30%

Ulcer Index

Depth and duration of drawdowns from previous peaks

37.12%

61.02%

-23.90%

Volatility

LTRN vs. DVLT - Volatility Comparison

Lantern Pharma Inc. (LTRN) and Datavault AI Inc (DVLT) have volatilities of 33.75% and 33.22%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


LTRNDVLTDifference

Volatility (1M)

Calculated over the trailing 1-month period

33.75%

33.22%

+0.53%

Volatility (6M)

Calculated over the trailing 6-month period

89.61%

109.67%

-20.06%

Volatility (1Y)

Calculated over the trailing 1-year period

96.91%

206.73%

-109.82%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

85.34%

192.66%

-107.32%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

85.19%

166.59%

-81.40%

Dividends

LTRN vs. DVLT - Dividend Comparison

Neither LTRN nor DVLT has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

LTRN vs. DVLT - Financials Comparison

This section allows you to compare key financial metrics between Lantern Pharma Inc. and Datavault AI Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00M10.00M15.00M20.00M25.00M30.00M35.00M202220232024202520260
917.00K
(LTRN) Total Revenue
(DVLT) Total Revenue
Values in USD except per share items

Frequently Asked Questions


LTRN and DVLT have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

LTRN has higher volatility (33.75%) compared to DVLT (33.22%). In terms of maximum drawdown, LTRN dropped -94.89% vs DVLT's -100.00%.

LTRN currently has the higher Sharpe Ratio (0.06 vs -0.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for LTRN and DVLT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer